Cork-based biotechnology company Metabolomic Diagnostics has secured a further $2m (€1.6m) in funding to complete the development of its life-saving screening test for pregnant mothers which it hopes to launch next year.

It’s often a good idea for startup founders to have a close familiarity with their product. For one scientist, contracting the tropical disease for which he’s attempting to provide a revolutionary diagnosis was not part of the plan.